NASDAQ:AMED - Amedisys Home Health and Hospice Care Stock Price, Price Target & More

$66.44 -0.86 (-1.28 %)
(As of 04/25/2018 03:03 AM ET)
Previous Close$67.30
Today's Range$66.11 - $68.50
52-Week Range$45.60 - $68.50
Volume218,264 shs
Average Volume292,306 shs
Market Capitalization$2.27 billion
P/E Ratio30.06
Dividend YieldN/A
Beta0.65

About Amedisys Home Health and Hospice Care (NASDAQ:AMED)

Amedisys Home Health and Hospice Care logoAmedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses, physical and speech therapists, occupational therapists, and aides for its patients to complete their important personal tasks. The Hospice segment offers care that is designed to provide comfort and support for those who are dealing with a terminal illness, including heart disease, pulmonary disease, Alzheimer's, HIV/AIDS, and cancer. The Personal Care segment provides assistance for patients with the activities of daily living. As of February 27, 2018, the company owned and operated 421 care centers in 34 states. Amedisys, Inc. was founded in 1982 and is headquartered in Baton Rouge, Louisiana.

Receive AMED News and Ratings via Email

Sign-up to receive the latest news and ratings for AMED and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Home health care services
Sub-IndustryHealth Care Services
SectorMedical
SymbolNASDAQ:AMED
CUSIP02343610
Phone225-292-2031

Debt

Debt-to-Equity Ratio0.15%
Current Ratio1.45%
Quick Ratio1.45%

Price-To-Earnings

Trailing P/E Ratio30.06
Forward P/E Ratio22.15
P/E Growth1.27

Sales & Book Value

Annual Sales$1.53 billion
Price / Sales1.47
Cash Flow$2.7466 per share
Price / Cash24.19
Book Value$15.22 per share
Price / Book4.37

Profitability

EPS (Most Recent Fiscal Year)$2.21
Net Income$30.30 million
Net Margins1.98%
Return on Equity15.14%
Return on Assets9.56%

Miscellaneous

Employees17,900
Outstanding Shares33,990,000

How to Become a New Pot Stock Millionaire

Amedisys Home Health and Hospice Care (NASDAQ:AMED) Frequently Asked Questions

What is Amedisys Home Health and Hospice Care's stock symbol?

Amedisys Home Health and Hospice Care trades on the NASDAQ under the ticker symbol "AMED."

How were Amedisys Home Health and Hospice Care's earnings last quarter?

Amedisys Home Health and Hospice Care (NASDAQ:AMED) announced its earnings results on Tuesday, February, 27th. The health services provider reported $0.56 earnings per share for the quarter, missing the consensus estimate of $0.58 by $0.02. The health services provider earned $404.24 million during the quarter, compared to analysts' expectations of $394.96 million. Amedisys Home Health and Hospice Care had a net margin of 1.98% and a return on equity of 15.14%. During the same quarter last year, the business posted $0.44 earnings per share. View Amedisys Home Health and Hospice Care's Earnings History.

When is Amedisys Home Health and Hospice Care's next earnings date?

Amedisys Home Health and Hospice Care is scheduled to release their next quarterly earnings announcement on Monday, April, 30th 2018. View Earnings Estimates for Amedisys Home Health and Hospice Care.

What guidance has Amedisys Home Health and Hospice Care issued on next quarter's earnings?

Amedisys Home Health and Hospice Care issued an update on its FY18 earnings guidance on Tuesday, February, 27th. The company provided earnings per share (EPS) guidance of $2.97-3.08 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.66. The company issued revenue guidance of $1.60-1.64 billion, compared to the consensus revenue estimate of $1.63 billion.

What price target have analysts set for AMED?

11 Wall Street analysts have issued twelve-month price objectives for Amedisys Home Health and Hospice Care's shares. Their forecasts range from $54.00 to $70.00. On average, they anticipate Amedisys Home Health and Hospice Care's stock price to reach $62.90 in the next twelve months. View Analyst Ratings for Amedisys Home Health and Hospice Care.

Who are some of Amedisys Home Health and Hospice Care's key competitors?

Some companies that are related to Amedisys Home Health and Hospice Care include Chemed (CHE), LHC Group (LHCG), Addus HomeCare (ADUS), Civitas Solutions (CIVI), BioScrip (BIOS) and New York Health Care (BBAL).

Who are Amedisys Home Health and Hospice Care's key executives?

Amedisys Home Health and Hospice Care's management team includes the folowing people:
  • Mr. Paul Berthold Kusserow, Chief Exec. Officer, Pres and Director (Age 57)
  • Mr. Scott G. Ginn, CFO & Principal Accounting Officer (Age 49)
  • Mr. Christopher T. Gerard, Chief Operating Officer (Age 51)
  • Mr. Pete Hartley, Chief Technology Officer and Sr. VP of Bus. Operations Systems
  • Mr. Michael P. North, Chief Information Officer (Age 53)

Has Amedisys Home Health and Hospice Care been receiving favorable news coverage?

News coverage about AMED stock has been trending positive recently, according to Accern Sentiment. The research firm identifies positive and negative news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Amedisys Home Health and Hospice Care earned a media sentiment score of 0.35 on Accern's scale. They also gave news coverage about the health services provider an impact score of 48.19 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

Who are Amedisys Home Health and Hospice Care's major shareholders?

Amedisys Home Health and Hospice Care's stock is owned by a variety of of institutional and retail investors. Top institutional investors include FMR LLC (2.94%). Company insiders that own Amedisys Home Health and Hospice Care stock include Bruce D Perkins, David B Pearce, Jake L Netterville, Lawrence R Pernosky and Scott G Ginn. View Institutional Ownership Trends for Amedisys Home Health and Hospice Care.

How do I buy shares of Amedisys Home Health and Hospice Care?

Shares of AMED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Amedisys Home Health and Hospice Care's stock price today?

One share of AMED stock can currently be purchased for approximately $66.44.

How big of a company is Amedisys Home Health and Hospice Care?

Amedisys Home Health and Hospice Care has a market capitalization of $2.27 billion and generates $1.53 billion in revenue each year. The health services provider earns $30.30 million in net income (profit) each year or $2.21 on an earnings per share basis. Amedisys Home Health and Hospice Care employs 17,900 workers across the globe.

How can I contact Amedisys Home Health and Hospice Care?

Amedisys Home Health and Hospice Care's mailing address is 3854 AMERICAN WAY SUITE A, BATON ROUGE LA, 70816. The health services provider can be reached via phone at 225-292-2031 or via email at [email protected]


MarketBeat Community Rating for Amedisys Home Health and Hospice Care (AMED)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  218 (Vote Outperform)
Underperform Votes:  384 (Vote Underperform)
Total Votes:  602
MarketBeat's community ratings are surveys of what our community members think about Amedisys Home Health and Hospice Care and other stocks. Vote "Outperform" if you believe AMED will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AMED will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Amedisys Home Health and Hospice Care (NASDAQ:AMED) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
11 Wall Street analysts have issued ratings and price targets for Amedisys Home Health and Hospice Care in the last 12 months. Their average twelve-month price target is $62.90, suggesting that the stock has a possible downside of 5.33%. The high price target for AMED is $70.00 and the low price target for AMED is $54.00. There are currently 4 hold ratings and 7 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyHold
Consensus Rating Score: 2.642.642.552.40
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $62.90$62.90$61.00$56.20
Price Target Upside: 5.33% downside0.27% upside15.79% upside11.80% upside

Amedisys Home Health and Hospice Care (NASDAQ:AMED) Consensus Price Target History

Price Target History for Amedisys Home Health and Hospice Care (NASDAQ:AMED)

Amedisys Home Health and Hospice Care (NASDAQ:AMED) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/19/2018Royal Bank of CanadaUpgradeSector Perform -> OutperformLowView Rating Details
3/1/2018Robert W. BairdSet Price TargetNeutral -> Hold$60.00 -> $66.00MediumView Rating Details
3/1/2018OppenheimerBoost Price TargetOutperform$68.00 -> $63.00HighView Rating Details
2/28/2018Jefferies GroupSet Price TargetBuy$70.00MediumView Rating Details
11/21/2017William BlairReiterated RatingOutperformN/AView Rating Details
11/10/2017SunTrust BanksReiterated RatingBuy$70.00N/AView Rating Details
11/9/2017Craig HallumReiterated RatingBuy$55.00 -> $68.00N/AView Rating Details
11/9/2017BenchmarkReiterated RatingBuy -> HoldN/AView Rating Details
11/8/2017MizuhoReiterated RatingBuy$55.00 -> $65.00N/AView Rating Details
8/21/2017Bank of AmericaInitiated CoverageNeutral -> Neutral$55.00LowView Rating Details
5/4/2017StephensBoost Price TargetEqual Weight$50.00 -> $54.00LowView Rating Details
9/11/2016Wells FargoReiterated RatingBuyN/AView Rating Details
(Data available from 4/25/2016 forward)

Earnings

Amedisys Home Health and Hospice Care (NASDAQ:AMED) Earnings History and Estimates Chart

Earnings by Quarter for Amedisys Home Health and Hospice Care (NASDAQ:AMED)

Amedisys Home Health and Hospice Care (NASDAQ:AMED) Earnings Estimates

2018 EPS Consensus Estimate: $2.90
2019 EPS Consensus Estimate: $3.32
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20184$0.59$0.69$0.65
Q2 20184$0.63$0.77$0.73
Q3 20184$0.67$0.78$0.75
Q4 20184$0.70$0.82$0.77
Q1 20193$0.68$0.74$0.72
Q2 20193$0.71$0.87$0.81
Q3 20192$0.87$0.87$0.87
Q4 20192$0.91$0.93$0.92

Amedisys Home Health and Hospice Care (NASDAQ AMED) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/30/2018$0.63N/AView Earnings Details
2/27/2018Q4 2017$0.58$0.56$394.96 million$404.24 millionViewListenView Earnings Details
11/7/2017Q3 2017$0.54$0.56$384.59 million$380.20 millionViewN/AView Earnings Details
7/26/2017Q2 2017$0.50$0.62$380.80 million$378.80 millionViewN/AView Earnings Details
5/2/2017Q1 2017$0.4080$0.47$370.03 million$370.46 millionViewListenView Earnings Details
2/28/2017Q4 2016$0.39$0.44$368.14 million$366.30 millionViewN/AView Earnings Details
11/3/2016Q3$0.36$0.36$361.08 million$361.60 millionViewListenView Earnings Details
8/2/2016Q2$0.42$0.42$353.07 million$360.00 millionViewListenView Earnings Details
5/3/2016Q1$0.33$0.33$337.07 million$348.80 millionViewListenView Earnings Details
3/8/2016Q415$0.35$0.40$322.67 million$338.37 millionViewListenView Earnings Details
11/5/2015Q315$0.34$0.34$312.22 million$326.50 millionViewListenView Earnings Details
7/29/2015Q215$0.33$0.43$307.11 million$314.20 millionViewListenView Earnings Details
4/29/2015Q115$0.20$0.30$300.17 million$301.60 millionViewListenView Earnings Details
3/4/2015Q414$0.27$0.27$301.62 million$300.50 millionViewListenView Earnings Details
10/29/2014Q314$0.17$0.28$299.26 million$300.30 millionViewListenView Earnings Details
7/30/2014Q214$0.17$0.25$298.90 million$305.00 millionViewListenView Earnings Details
5/8/2014Q114($0.06)($0.07)$301.89 million$298.74 millionViewListenView Earnings Details
3/12/2014Q413($0.01)($0.05)$295.02 million$303.50 millionViewListenView Earnings Details
11/12/2013Q313$0.13$0.06$314.30 million$301.64 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.10$0.06$328.02 million$313.10 millionViewListenView Earnings Details
4/30/2013Q1 2013$0.18$0.13$361.41 million$339.20 millionViewListenView Earnings Details
3/12/2013Q4 2012$0.22$0.24$373.31 million$632.90 millionViewListenView Earnings Details
11/6/2012Q312$0.27$0.33$379.97 million$375.62 millionViewN/AView Earnings Details
8/7/2012$0.24$0.27ViewN/AView Earnings Details
5/8/2012$0.22$0.22ViewN/AView Earnings Details
2/28/2012$0.29$0.25ViewN/AView Earnings Details
11/1/2011$0.50$0.36ViewN/AView Earnings Details
8/2/2011$0.69$0.75ViewN/AView Earnings Details
4/26/2011$0.66$0.53ViewN/AView Earnings Details
2/22/2011$0.91$0.77ViewN/AView Earnings Details
10/26/2010Q3 2010$0.91$0.89ViewN/AView Earnings Details
8/9/2010Q2 2010$1.17$1.13ViewN/AView Earnings Details
4/27/2010Q1 2010$1.28$1.29ViewN/AView Earnings Details
2/23/2010Q4 2009$1.32$1.35ViewN/AView Earnings Details
10/27/2009Q3 2009$1.27$1.29ViewN/AView Earnings Details
7/28/2009Q2 2009$1.02$1.27ViewN/AView Earnings Details
4/28/2009Q1 2009$0.97$0.99ViewN/AView Earnings Details
2/17/2009Q4 2008$0.91$0.98ViewN/AView Earnings Details
10/28/2008Q3 2008$0.82$0.89ViewN/AView Earnings Details
7/29/2008Q2 2008$0.68$0.76ViewN/AView Earnings Details
4/30/2008Q1 2008$0.57$0.62ViewN/AView Earnings Details
2/27/2008Q4 2007$0.60$0.63ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Amedisys Home Health and Hospice Care (NASDAQ:AMED) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Amedisys Home Health and Hospice Care (NASDAQ AMED) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.00%
Institutional Ownership Percentage: 95.41%
Insider Trading History for Amedisys Home Health and Hospice Care (NASDAQ:AMED)
Institutional Ownership by Quarter for Amedisys Home Health and Hospice Care (NASDAQ:AMED)

Amedisys Home Health and Hospice Care (NASDAQ AMED) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/8/2017David B PearceInsiderSell1,000$50.00$50,000.0010,488View SEC Filing  
8/3/2017Bruce D PerkinsDirectorBuy2,000$46.60$93,200.0015,825View SEC Filing  
5/25/2017Bruce D PerkinsDirectorBuy500$59.69$29,845.0013,331View SEC Filing  
5/12/2017Jake L NettervilleDirectorSell10,000$60.00$600,000.0077,499View SEC Filing  
5/10/2017Lawrence R PernoskyInsiderSell11,500$58.97$678,155.0030,093View SEC Filing  
5/9/2017Lawrence R PernoskyInsiderSell11,500$58.78$675,970.0030,093View SEC Filing  
5/8/2017Scott G GinnInsiderSell23,828$58.62$1,396,797.3613,018View SEC Filing  
5/13/2016Bruce D PerkinsDirectorBuy1,000$50.21$50,210.0010,354View SEC Filing  
5/11/2016Scott G GinnInsiderSell6,000$51.62$309,720.0048,009View SEC Filing  
11/2/2015North Tide Capital, LlcMajor ShareholderSell277,720$39.79$11,050,478.80View SEC Filing  
10/28/2015North Tide Capital, LlcMajor ShareholderSell191,400$39.86$7,629,204.00View SEC Filing  
10/26/2015North Tide Capital, LlcMajor ShareholderSell56,400$39.32$2,217,648.00View SEC Filing  
8/18/2015Donald A WashburnDirectorSell20,000$45.51$910,200.00View SEC Filing  
3/13/2015Jeffrey D JeterInsiderSell11,264$27.02$304,353.28View SEC Filing  
3/13/2015Peter RicchiutiDirectorSell2,003$27.25$54,581.75View SEC Filing  
8/5/2014Jeffrey D JeterInsiderSell2,500$21.80$54,500.00View SEC Filing  
5/8/2014North Tide Capital, Llcmajor shareholderBuy500,000$13.90$6,950,000.00View SEC Filing  
5/1/2014North Tide Capital, Llcmajor shareholderBuy150,000$13.54$2,031,000.00View SEC Filing  
11/21/2013Kkr Asset Management Llcmajor shareholderBuy425,515$14.48$6,161,457.20View SEC Filing  
11/15/2013David BuceyGeneral CounselSell8,290$13.95$115,645.5013,057View SEC Filing  
11/14/2013Kkr Asset Management Llcmajor shareholderBuy946,500$13.89$13,146,885.00View SEC Filing  
10/30/2013Kkr Asset Management LlcMajor ShareholderBuy29,615$15.94$472,063.10View SEC Filing  
10/22/2013Kkr Asset Management LlcMajor ShareholderBuy186,013$17.55$3,264,528.15View SEC Filing  
10/18/2013Kkr Asset Management LlcMajor ShareholderBuy12,652$17.95$227,103.40View SEC Filing  
7/3/2013Linda J HallDirectorSell1,721$10.65$18,328.65View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Amedisys Home Health and Hospice Care (NASDAQ AMED) News Headlines

Source:
DateHeadline
Amedisys Home Health and Hospice Care (AMED) Scheduled to Post Earnings on MondayAmedisys Home Health and Hospice Care (AMED) Scheduled to Post Earnings on Monday
www.americanbankingnews.com - April 23 at 7:14 AM
BioScrip (BIOS) versus Amedisys Home Health and Hospice Care (AMED) Head to Head ContrastBioScrip (BIOS) versus Amedisys Home Health and Hospice Care (AMED) Head to Head Contrast
www.americanbankingnews.com - April 20 at 11:16 PM
$396.66 Million in Sales Expected for Amedisys Home Health and Hospice Care (AMED) This Quarter$396.66 Million in Sales Expected for Amedisys Home Health and Hospice Care (AMED) This Quarter
www.americanbankingnews.com - April 20 at 1:56 AM
Amedisys Home Health and Hospice Care (AMED) Receives Consensus Recommendation of "Buy" from AnalystsAmedisys Home Health and Hospice Care (AMED) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - April 19 at 11:31 AM
Zacks: Brokerages Expect Amedisys Home Health and Hospice Care (AMED) to Announce $0.66 Earnings Per ShareZacks: Brokerages Expect Amedisys Home Health and Hospice Care (AMED) to Announce $0.66 Earnings Per Share
www.americanbankingnews.com - April 18 at 9:14 PM
Amedisys Home Health and Hospice Care (AMED) Stock Rating Lowered by BidaskClubAmedisys Home Health and Hospice Care (AMED) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - April 18 at 6:54 PM
Amedisys Home Health and Hospice Care (AMED) Upgraded by BidaskClub to HoldAmedisys Home Health and Hospice Care (AMED) Upgraded by BidaskClub to Hold
www.americanbankingnews.com - April 10 at 7:19 PM
Amedisys Home Health and Hospice Care (AMED) Receives Hold Rating from Robert W. BairdAmedisys Home Health and Hospice Care (AMED) Receives Hold Rating from Robert W. Baird
www.americanbankingnews.com - April 7 at 9:54 PM
Amedisys Home Health and Hospice Care (AMED) Upgraded to "Strong-Buy" by BidaskClubAmedisys Home Health and Hospice Care (AMED) Upgraded to "Strong-Buy" by BidaskClub
www.americanbankingnews.com - April 6 at 11:17 AM
Zacks: Brokerages Anticipate Amedisys Home Health and Hospice Care (AMED) Will Post Quarterly Sales of $396.66 MillionZacks: Brokerages Anticipate Amedisys Home Health and Hospice Care (AMED) Will Post Quarterly Sales of $396.66 Million
www.americanbankingnews.com - April 3 at 2:12 AM
Amedisys Home Health and Hospice Care (AMED) Rating Increased to Buy at MizuhoAmedisys Home Health and Hospice Care (AMED) Rating Increased to Buy at Mizuho
www.americanbankingnews.com - April 2 at 8:22 AM
Amedisys Home Health and Hospice Care (AMED) Upgraded to Buy at BenchmarkAmedisys Home Health and Hospice Care (AMED) Upgraded to Buy at Benchmark
www.americanbankingnews.com - April 2 at 12:30 AM
Amedisys Home Health and Hospice Care (AMED) Expected to Post Earnings of $0.66 Per ShareAmedisys Home Health and Hospice Care (AMED) Expected to Post Earnings of $0.66 Per Share
www.americanbankingnews.com - April 1 at 9:20 PM
Amedisys Home Health and Hospice Care (AMED) Receives "Buy" Rating from MizuhoAmedisys Home Health and Hospice Care (AMED) Receives "Buy" Rating from Mizuho
www.americanbankingnews.com - April 1 at 10:34 AM
Amedisys Home Health and Hospice Cares (AMED) "Hold" Rating Reiterated at BenchmarkAmedisys Home Health and Hospice Care's (AMED) "Hold" Rating Reiterated at Benchmark
www.americanbankingnews.com - March 31 at 7:10 PM
Royal Bank of Canada Reiterates "Sector Perform" Rating for Amedisys Home Health and Hospice Care (AMED)Royal Bank of Canada Reiterates "Sector Perform" Rating for Amedisys Home Health and Hospice Care (AMED)
www.americanbankingnews.com - March 31 at 7:10 PM
Amedisys (AMED) Up 1.9% Since Earnings Report: Can It Continue?Amedisys (AMED) Up 1.9% Since Earnings Report: Can It Continue?
finance.yahoo.com - March 29 at 4:44 PM
Amedisys (AMED) Lowered to Strong Sell at BidaskClubAmedisys (AMED) Lowered to Strong Sell at BidaskClub
www.americanbankingnews.com - March 28 at 9:48 PM
Amedisys Inc (AMED) Receives Consensus Recommendation of "Buy" from AnalystsAmedisys Inc (AMED) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - March 25 at 11:41 AM
Amedisys (AMED) Upgraded to Sell at BidaskClubAmedisys (AMED) Upgraded to Sell at BidaskClub
www.americanbankingnews.com - March 25 at 9:30 AM
Amedisys (AMED) Given a $70.00 Price Target by Jefferies Group AnalystsAmedisys (AMED) Given a $70.00 Price Target by Jefferies Group Analysts
www.americanbankingnews.com - March 24 at 5:44 PM
Amedisys (AMED) Stock Rating Lowered by Zacks Investment ResearchAmedisys (AMED) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - March 20 at 5:48 PM
What to Expect from Amedisys in 2018What to Expect from Amedisys in 2018
finance.yahoo.com - March 19 at 9:16 AM
How Amedisys Has Performed FinanciallyHow Amedisys Has Performed Financially
finance.yahoo.com - March 19 at 9:16 AM
Amedisys (AMED) Upgraded by Royal Bank of Canada to "Outperform"Amedisys (AMED) Upgraded by Royal Bank of Canada to "Outperform"
www.americanbankingnews.com - March 19 at 8:02 AM
BidaskClub Upgrades Amedisys (AMED) to BuyBidaskClub Upgrades Amedisys (AMED) to Buy
www.americanbankingnews.com - March 17 at 7:16 PM
 Brokerages Anticipate Amedisys Inc (AMED) Will Post Quarterly Sales of $396.66 Million Brokerages Anticipate Amedisys Inc (AMED) Will Post Quarterly Sales of $396.66 Million
www.americanbankingnews.com - March 17 at 2:48 AM
$0.66 EPS Expected for Amedisys Inc (AMED) This Quarter$0.66 EPS Expected for Amedisys Inc (AMED) This Quarter
www.americanbankingnews.com - March 15 at 7:20 PM
CMS Rating for Amedisys Home Health Rises to Average of 4.22 StarsCMS Rating for Amedisys Home Health Rises to Average of 4.22 Stars
finance.yahoo.com - March 15 at 9:00 AM
Amedisys to Present at the 28th Annual Oppenheimer Healthcare ConferenceAmedisys to Present at the 28th Annual Oppenheimer Healthcare Conference
finance.yahoo.com - March 14 at 9:58 AM
5 Growth Stocks in MedTech Set to Scale Higher in 20185 Growth Stocks in MedTech Set to Scale Higher in 2018
finance.yahoo.com - March 12 at 11:37 AM
Amedisys (AMED) Strong on Buyouts & Solid Personal Care UnitAmedisys (AMED) Strong on Buyouts & Solid Personal Care Unit
finance.yahoo.com - March 7 at 9:15 AM
Amedisys (AMED) Stock Rating Upgraded by Zacks Investment ResearchAmedisys (AMED) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - March 6 at 9:46 PM
Amedisys Inc (AMED) Shares Bought by Schwab Charles Investment Management Inc.Amedisys Inc (AMED) Shares Bought by Schwab Charles Investment Management Inc.
www.americanbankingnews.com - March 6 at 5:56 AM
Amedisys Closes on Acquisition Adding Coverage Area in Western KentuckyAmedisys Closes on Acquisition Adding Coverage Area in Western Kentucky
finance.yahoo.com - March 5 at 9:13 AM
Oppenheimer Brokers Increase Earnings Estimates for Amedisys Inc (AMED)Oppenheimer Brokers Increase Earnings Estimates for Amedisys Inc (AMED)
www.americanbankingnews.com - March 5 at 7:04 AM
Jefferies Group Weighs in on Amedisys Incs FY2018 Earnings (AMED)Jefferies Group Weighs in on Amedisys Inc's FY2018 Earnings (AMED)
www.americanbankingnews.com - March 5 at 7:04 AM
Amedisys Inc to Post FY2018 Earnings of $3.00 Per Share, William Blair Forecasts (AMED)Amedisys Inc to Post FY2018 Earnings of $3.00 Per Share, William Blair Forecasts (AMED)
www.americanbankingnews.com - March 5 at 7:04 AM
Amedisys Inc (AMED) Holdings Decreased by Sei Investments Co.Amedisys Inc (AMED) Holdings Decreased by Sei Investments Co.
www.americanbankingnews.com - March 4 at 9:08 AM
Amedisys (AMED) Rating Lowered to C+ at TheStreetAmedisys (AMED) Rating Lowered to C+ at TheStreet
www.americanbankingnews.com - March 3 at 7:48 PM
Globeflex Capital L P Invests $1.02 Million in Amedisys Inc (AMED) StockGlobeflex Capital L P Invests $1.02 Million in Amedisys Inc (AMED) Stock
www.americanbankingnews.com - March 2 at 3:49 PM
OppenheimerFunds Inc. Has $29.33 Million Stake in Amedisys Inc (AMED)OppenheimerFunds Inc. Has $29.33 Million Stake in Amedisys Inc (AMED)
www.americanbankingnews.com - March 2 at 11:49 AM
Q1 2018 EPS Estimates for Amedisys Inc (AMED) Lifted by AnalystQ1 2018 EPS Estimates for Amedisys Inc (AMED) Lifted by Analyst
www.americanbankingnews.com - March 2 at 10:15 AM
Analysts Offer Predictions for Amedisys Incs Q1 2018 Earnings (AMED)Analysts Offer Predictions for Amedisys Inc's Q1 2018 Earnings (AMED)
www.americanbankingnews.com - March 2 at 10:15 AM
William Blair Equities Analysts Raise Earnings Estimates for Amedisys Inc (AMED)William Blair Equities Analysts Raise Earnings Estimates for Amedisys Inc (AMED)
www.americanbankingnews.com - March 2 at 10:15 AM
Amedisys (AMED) Q4 Earnings Miss, Revenues Beat EstimatesAmedisys (AMED) Q4 Earnings Miss, Revenues Beat Estimates
finance.yahoo.com - March 1 at 5:07 PM
Amedisys (AMED) Given New $63.00 Price Target at OppenheimerAmedisys (AMED) Given New $63.00 Price Target at Oppenheimer
www.americanbankingnews.com - March 1 at 5:05 PM
Robert W. Baird Analysts Give Amedisys (AMED) a $66.00 Price TargetRobert W. Baird Analysts Give Amedisys (AMED) a $66.00 Price Target
www.americanbankingnews.com - March 1 at 3:16 PM
Amedisys Inc (AMED) Files 10-K for the Fiscal Year Ended on December 31, 2017Amedisys Inc (AMED) Files 10-K for the Fiscal Year Ended on December 31, 2017
finance.yahoo.com - March 1 at 8:54 AM
AMEDISYS Inc 2017 Q4 - Results - Earnings Call SlidesAMEDISYS Inc 2017 Q4 - Results - Earnings Call Slides
seekingalpha.com - February 28 at 5:18 PM

SEC Filings

Amedisys Home Health and Hospice Care (NASDAQ:AMED) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Amedisys Home Health and Hospice Care (NASDAQ:AMED) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Amedisys Home Health and Hospice Care (NASDAQ AMED) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.